Boston Scientific Corporation · NYSE:BSX
Boston Scientific — Investor Presentation (2013)
7 slides from Boston Scientific's investor presentation, 2013
Slide 1: Physician-Industry Transparency: The U.S. Physician Payment Sunshine Act
Physician-Industry Transparency: The U.S. Physician Payment Sunshine Act 1
Slide 2: The Sunshine Act
The Sunshine Act The Sunshine Act will make interactions between U.S. physicians and pharmaceutical, biologics and medical device manufacturers significantly more visible to the public. Boston Scientific has developed systems to enable accurate tracking and reporting of payments and items of value p
Slide 3: Rollout Dates & Requirements
Rollout Dates & Requirements 2013 AUG 1 2014 MAR 31 SEP 30 Beginning August 1, 2013: Beginning March 31, 2014: September 30, 2014: Pharmaceutical, biologic and Pharmaceutical, biologic and The U.S. government will post medical device companies medical device companies are data on a public, searchabl
Slide 4: What Information are Pharmaceutical, Biologics and Medical Device Companies Required to Report?
What Information are Pharmaceutical, Biologics and Medical Device Companies Required to Report? • All payments or transfers of value to a U.S. physician or teaching hospital over $10. • Any payments made to another entity “at the Types of payments or items of value that request of” or “on behalf of”
Slide 5: What Information are Pharmaceutical, Biologics and Medical Device Companies Required to Report?
What Information are Pharmaceutical, Biologics and Medical Device Companies Required to Report? Sunshine Act Reporting Requirements: • Name of recipient HCP, contact information, specialty INCLUDED • HCP’s National Provider Identifier • State License Number of HCP • Date of the payment or transfer o
Slide 6: How Can Physicians Prepare?
How Can Physicians Prepare? Physicians can prepare by: ► Reviewing their hospital/medical facility policies that limit interaction with industry and avoiding interactions that are not consistent with those policies. ► Understanding and being comfortable with the reason for any payments or transfers
Slide 7: In Closing
In Closing We value and look forward to continuing our essential collaboration with physicians, hospitals and other health care providers, which allows us to deliver innovative, less-invasive medical devices and procedures for the benefit of patients. We are committed to acting with integrity in all